TLX Company Profile and Key Details

NASDAQ : TLX

Telix Pharmaceuticals

$10.56

-0.3-2.76%

At Close 4:00 PM

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Telix Pharmaceuticals Limited (TLX) stock declined over -2.76%, trading at $10.56 on NASDAQ, down from the previous close of $10.86. The stock opened at $10.68, fluctuating between $10.53 and $10.68 in the recent session.

Stock Snapshot

10.86

Prev. Close

3.58B

Market Cap

10.525

Day Low

-528

P/E Ratio

-0.02

EPS (TTM)

N/A

Cash Flow per Share

10.68

Open

338.78M

Number of Shares

10.68

Day High

81.37%

Free Float in %

N/A

Book Value

80.23K

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
May 15, 2026	10.68	10.78	10.24	10.56	80.23K
May 14, 2026	10.55	10.91	10.54	10.86	100.64K
May 13, 2026	10.42	10.57	10.40	10.52	75.83K
May 12, 2026	10.62	10.63	10.26	10.39	132.82K
May 11, 2026	10.89	11.04	10.72	10.83	157.23K
May 08, 2026	10.69	10.86	10.64	10.68	193.36K
May 07, 2026	11.05	11.05	10.61	10.66	141.97K
May 06, 2026	11.00	11.15	10.90	11.11	79.85K
May 05, 2026	11.15	11.15	10.97	11.04	89.21K
May 04, 2026	11.28	11.30	11.09	11.15	66.4K
Apr 30, 2026	10.53	11.03	10.53	11.00	220.47K
Apr 29, 2026	10.49	10.53	10.39	10.43	116.55K
Apr 28, 2026	10.47	10.52	10.42	10.44	71.58K
Apr 27, 2026	10.45	10.48	10.32	10.40	95.39K
Apr 23, 2026	10.35	10.38	10.06	10.19	133.1K
Apr 22, 2026	10.31	10.39	10.29	10.33	143.11K
Apr 21, 2026	10.50	10.51	10.23	10.23	163.07K
Apr 20, 2026	10.74	10.77	10.63	10.73	151.44K
Apr 17, 2026	10.71	10.83	10.68	10.74	301.04K
Apr 16, 2026	10.92	11.25	10.74	10.74	302.77K

Contact Details

North Melbourne, VIC 3051

Australia

https://telixpharma.com 613 909 33855

About Company

Telix Pharmaceuticals Limited, a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals for cancer and rare diseases in Australia, Belgium, Japan, Switzerland, and the United States. The company offers Illuccix for the treatment of prostate cancer; and TLX66-CDx for the treatment of imaging osteomyelitis. Its products candidates include TLX591, a radio antibody-drug conjugate for the treatment of prostate cancer; TLX250-CDx for the treatment and diagnosis of renal (kidney) cancer; TLX101-CDx for brain (glioma) cancer; TLX66-CDx to treat bone marrow conditioning; TLX300-CDx for the treatment and diagnosis of soft tissue sarcoma; and TLX250 for the treatment of clear cell renal cell carcinoma. The company also develops TLX101 for the treatment of glioblastoma (brain cancer); TLX66 for the treatment of bone marrow conditioning; TLX300 for the treatment of soft tissue sarcoma; and TLX592, a prostate cancer therapy candidate for targeted alpha therapy. Telix Pharmaceuticals Limited was founded in 2015 and is headquartered in North Melbourne, Australia.

Stock Peers

ARGX

-22.81-2.77%

argenx SE$799.32 REGN

-14.62-2.05%

Regeneron Pharmaceuticals, Inc.$698.25 UTHR

-7.21-1.25%

United Therapeutics Corporation$568.58 MDGL

-16.2-3.00%

Madrigal Pharmaceuticals, Inc.$523.69 VRTX

-13.46-2.99%

Vertex Pharmaceuticals Incorporated$436.95 PRAX

-2.94-0.85%

Praxis Precision Medicines, Inc.$342.58 KRTX

0.09+0.03%

Karuna Therapeutics, Inc.$329.83 KRYS

-10.01-3.16%

Krystal Biotech, Inc.$306.29 ALNY

-6.47-2.20%

Alnylam Pharmaceuticals, Inc.$286.98 ASND

-4.99-2.03%

Ascendis Pharma A/S$240.50

Frequently Asked Questions

What is the current Telix Pharmaceuticals Limited (TLX) stock price?

Telix Pharmaceuticals Limited (NASDAQ: TLX) stock price is $10.56 in the last trading session. During the trading session, TLX stock reached the peak price of $10.68 while $10.53 was the lowest point it dropped to. The percentage change in TLX stock occurred in the recent session was -2.76% while the dollar amount for the price change in TLX stock was - $0.30.

TLX's industry and sector of operation?

The NASDAQ listed TLX is part of Biotechnology industry that operates in the broader Healthcare sector. Telix Pharmaceuticals Limited designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of TLX?

No Data

How TLX did perform over past 52-week?

TLX's closing price is 68.15% higher than its 52-week low of $6.28 where as its distance from 52-week high of $18.49 is -42.89%.

How many employees does TLX have?

Number of TLX employees currently stands at 0.

Link for TLX official website?

Official Website of TLX is: https://telixpharma.com

How do I contact TLX?

TLX could be contacted at phone 613 909 33855 and can also be accessed through its website. TLX operates from 55 Flemington Road, North Melbourne, VIC 3051, Australia.

How many shares of TLX are traded daily?

TLX stock volume for the day was 80.23K shares. The average number of TLX shares traded daily for last 3 months was 247.54K.

What is the market cap of TLX currently?

The market value of TLX currently stands at $3.58B with its latest stock price at $10.56 and 338.78M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	0
Beta	0.61
Sales or Revenue	N/A
5Y Sales Change%	-1%
Fiscal Year Ends	N/A
Sector	Healthcare
Industry	Biotechnology

Employees	0
Beta	0.61
Sales or Revenue	N/A
5Y Sales Change%	-1%
Fiscal Year Ends	N/A
Sector	Healthcare
Industry	Biotechnology

TLX Company Profile and Key Details

Telix Pharmaceuticals

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Shareholding & Insider Activity

Financial & Profitability Overview

Earnings & Analyst Outlook

Dividend & Fair Value

Company Overview

Valuation Metrics

Key Takeaways

Price Forecast & Outlook